Target intelligence / Profile preview

Antisperm antibody (ASA)

Target
ASA
Molecular classification
Immunoglobulin, Autoantibody, Other
01

Overview

Antisperm antibodies (ASA) are immunoglobulins—proteins produced by the immune system—that specifically bind to antigens on the surface of human sperm[1][7][9]. These antibodies can be of the IgG, IgA, or IgM class and are produced in response to the immune system mistaking sperm as foreign to the body, often after disruption of immunological barriers in the male (due to trauma, surgery, infections, or mucosal damage)[1][3][9]. In rare cases, women may also generate ASA, especially following inflammation or trauma in the reproductive tract[1][4]. ASA can impair fertility by binding to sperm and reducing their motility, interfering with their ability to penetrate cervical mucus, bind to the egg, or complete fertilization[3][7]. ASA are not molecular drug targets (like enzymes or receptors) but are clinically relevant as autoantibody markers in the diagnosis and management of immunological infertility[9]. Laboratory tests can detect antisperm antibodies in semen, blood, or cervical mucus using immunological assays such as the immunobead test or the mixed antiglobulin reaction[2][8][9]. No direct drugs or therapeutic agents target ASA themselves, but treatment of ASA-associated infertility sometimes involves immune suppression or assisted reproductive techniques (e.g., intrauterine insemination, IVF)[2][3][8]. Because ASA are not individual genes, proteins, or receptors, but rather a heterogeneous class of pathogenic antibodies, they are not considered classic therapeutic targets themselves.

Other names
Antisperm antibodiesAnti-sperm antibodyASAAntisperm autoantibodyAntisperm immunoglobulin
02

Biological functions

Immune responseOther
03

Disease associations

InfertilityImmune-mediated infertilityOther
04

Safety considerations

False positives/negatives in antibody testingOver-reliance on ASA testing for diagnosis of infertilityImmunosuppression risks if used therapeutically
05

Biomarkers

Antisperm antibody levels (in blood, semen, or cervical mucus) as a biomarker for immunological infertility

Beyond the preview

Go deeper on Antisperm antibody (ASA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antisperm antibody (ASA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call